| scholarly article | Q13442814 |
| P2093 | author name string | W. H. Clark | |
| T. I. Young | |||
| M. H. Greene | |||
| P2860 | cites work | Speculations on the Role of Ultraviolet Radiation in the Development of Malignant Melanoma4 | Q34169631 |
| Low natural-killer-cell activity in familial melanoma patients and their relatives | Q36043116 | ||
| Immunologic abnormalities in melanoma-prone families | Q39900092 | ||
| The immunobiology of human malignant melanoma | Q40291355 | ||
| Immune response to melanoma extracts in three melanoma-prone families | Q40620373 | ||
| Development of cancer in transplantation patients | Q40987499 | ||
| Skin Cancer in Immunosuppressed Patients | Q42438294 | ||
| Renal Transplantation and Cancer. The Scandia Transplant Material | Q43906000 | ||
| Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature | Q50717883 | ||
| A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods | Q52437315 | ||
| Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs | Q55652491 | ||
| Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome' | Q67324299 | ||
| Cancer in patients receiving dialysis | Q71353349 | ||
| Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma | Q71355891 | ||
| Genetic factor in malignant melanoma | Q71853403 | ||
| Reactivation of ocular malignant melanoma after renal transplantation | Q72134615 | ||
| Malignant melanoma in patient with renal transplant | Q72436368 | ||
| P433 | issue | 8231 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1196-1199 | |
| P577 | publication date | 1981-05-01 | |
| 1981-05-30 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Malignant melanoma in renal-transplant recipients | |
| P478 | volume | 1 |
| Q70214288 | Acral verrucous malignant melanoma in an immunosuppressed patient after kidney transplantation |
| Q42467855 | Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug |
| Q39738023 | Cancer after transplantation |
| Q41886382 | Cancer in organ transplant recipients: part of an induced immune deficiency syndrome. |
| Q36467788 | Cancer risk following pernicious anaemia |
| Q43685524 | Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ |
| Q34292032 | Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals |
| Q56921275 | Conjunctival malignant disease with AIDS in USA |
| Q43530332 | Cutaneous malignant melanoma and human immunodeficiency virus (HIV) infection: a report of three cases |
| Q43662290 | Cutaneous manifestations of chronic renal failure in children of color |
| Q38681400 | Cutaneous manifestations of immunosuppression in organ transplant recipients |
| Q73260225 | Dermatological perspectives of malignant melanoma |
| Q41493000 | Dermatology-important advances in clinical medicine: dysplastic nevus syndrome |
| Q70031903 | Diagnosis of the dysplastic nevus in different populations |
| Q41722524 | Donor transmission of melanoma following renal transplant |
| Q40335778 | Dowling Oration 1981. The changing face of melanoma |
| Q40232514 | Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas |
| Q71769649 | Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families |
| Q69786265 | Dysplastic nevus syndrome. Familial and sporadic precursors of cutaneous melanoma |
| Q35690314 | Effect of Medications on Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Population-Based Cohort Study from Olmsted County, Minnesota |
| Q45409643 | Eruptive acral naevi following chemotherapy for acute lymphoblastic leukaemia follow typical acral dermoscopic patterns |
| Q43688108 | Eruptive melanocytic nevi in human immunodeficiency virus infection |
| Q36647851 | Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland |
| Q35714256 | Excess benign melanocytic naevi after chemotherapy for malignancy in childhood |
| Q41561185 | HPV infections and immunosuppression |
| Q93542740 | Host-susceptibility factors in cancer etiology |
| Q34793496 | Increased risk of second primary cancers after a diagnosis of melanoma |
| Q77366760 | Issues in the epidemiology of melanoma |
| Q48119206 | Leptomeningeal melanoma and Creutzfeldt-Jakob disease in a patient with chronic lymphocytic leukaemia |
| Q36110282 | Malignant melanoma and filariasis: a coexistence or an association? |
| Q41285112 | Malignant melanoma from the dermatologic perspective |
| Q45843289 | Malignant melanoma in a man seropositive for the human immunodeficiency virus |
| Q42455222 | Malignant melanoma in an HIV-infected man: a case report and literature review |
| Q36103153 | Management of nevi in transplant patients |
| Q72569705 | Managing the dysplastic naevus syndrome |
| Q35194168 | Melacine: an allogeneic melanoma tumor cell lysate vaccine |
| Q39726048 | Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management. |
| Q58587556 | Melanoma in children, adolescents and young adults: anatomo-clinical features and prognostic study on 426 cases |
| Q36512842 | Melanoma in immunosuppressed patients |
| Q36440261 | Melanoma in organ transplant recipients: incidence, outcomes and management considerations |
| Q36979921 | Melanoma in organ transplant recipients: the old enemy finds a new battleground |
| Q48270523 | Melanoma in patients with GATA2 deficiency. |
| Q43259493 | Melanomas in renal transplant recipients: the London experience, and invitation to participate in a European study |
| Q38901338 | Metastatic melanoma and immunotherapy |
| Q40633676 | Nonsunlight risk factors for malignant melanoma. Part II: Immunity, genetics, and workplace prevention |
| Q77068561 | Number of acquired melanocytic nevi in renal transplant recipients as a risk factor for melanoma |
| Q42401787 | On the clinical significance of cutaneous melanoma's precursors |
| Q40154319 | Pigmented Birthmarks and Precursor Melanocytic Lesions of Cutaneous Melanoma Identifiable in Childhood |
| Q36766190 | Porokeratosis of Mibelli following heart transplant |
| Q37051177 | Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review |
| Q36090959 | Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma. |
| Q34164941 | Second malignancies in children: the usual suspects? |
| Q73999884 | Second malignancies in children: the usual suspects? |
| Q40457313 | Skin Cancers Associated With Acquired Immunodeficiency Syndrome |
| Q71731138 | Skin cancer |
| Q37432717 | Skin cancer after transplantation |
| Q42467117 | Skin cancer in Australian heart transplant recipients |
| Q72406298 | Skin cancer in immunosuppressed organ transplant recipients |
| Q38204473 | Survival after cutaneous melanoma in kidney transplant recipients: a population-based matched cohort study. |
| Q42476339 | The development of excess numbers of melanocytic naevi in an immunosuppressed identical twin. |
| Q33813969 | The genetics of hereditary melanoma and nevi. 1998 update |
| Q38270141 | The melanoma revolution: from UV carcinogenesis to a new era in therapeutics. |
| Q52873265 | The relationship of psoriasis to malignancy: a clinical report. |
| Q41027341 | Widespread eruptive dermal and atypical melanocytic nevi in association with chronic myelocytic leukemia: case report and review of the literature |
| Q80221762 | [Multiple post-chemotherapy plantar nevi] |
Search more.